1
Total Mentions
1
Documents
0
Connected Entities
HOUSE_OVERSIGHT_024631 - HOUSE_OVERSIGHT_024816
der the CSA Nasdaq Nasdaq Stock Market NDA New Drug Application; an application submitted by a drug manufacturer to the FDA for approval of a drug NYSE New York Stock Exchange 172 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC HOUSE_OVERSIGHT_024808 --- PAGE BREAK --- ACKR CAPI L EL TA CHAPTER X_ Glossary of Terms Oi
Page: HOUSE_OVERSIGHT_024811 →No connected entities